Pulmonary functions and imaging features of patients with chronic obstructive pulmonary disease combined with mild carbon dioxide retention

doi:10.3877/cma.j.issn.1674-6902.2020.01.005

Abstract

Abstract:

Objective

To investigate the pulmonary functions and imaging features of the patients with chronic obstructive pulmonary disease (COPD) combined with mild carbon dioxide (CO₂) retention in order to provide evidences for monitoring and treatment of this disease.

Methods

A total of 147 patients with acute exacerbation of COPD were included for this study. Sixty-one patients with the arterial carbon dioxide tension (PaCO₂) of 40-44.9 mm Hg were taken as the no-CO₂ retention group, 48 patients with PaCO₂ of 45-50 mmHg were taken as the mild CO₂ retention group, and 38 cases with PaCO₂ of more than 50 mmHg were taken as the respiratory failure group. The differences of the pulmonary functions and volume CT were compared between the three groups.

Results

In the mild CO₂ retention group, the pulmonary function parameters such as the percentage of predicted forced expiratory volume in one second (FEV₁%pred), CT value corresponding to the 15th percentile of lung density distribution (PD15) and the mean emphysema density (MED) were significantly different from those of the respiratory failure group (P<0.05). Spearman correlation analysis showed that PaCO₂ had a moderate negative correlation with FEV₁%pred and the percentage of predicted forced vital capacity (FVC%pred, r=-0.536 and -0.576, respectively, P<0.001) and a weak negative correlation with PD15 of the whole lungs (r=-0.325, P=0.002) and the MED of the whole lungs (r=-0.333, P=0.002).

Conclusion

The structure and functional characteristics of the COPD patients with mild CO₂ retention are similar to the COPD patients with no CO₂ retention. The COPD patients with PaCO₂>50 mmHg suffer from more severe pathological and pulmonary function damage. In the progression of mild CO₂ retention to type Ⅱ respiratory failure, the pulmonary function parameters combined with PD15 and MED may better reflect the disease.

Key words: Chronic obstructive pulmonary disease, Carbon dioxide retention, Pulmonary function test, CT imaging

Xia Wei, Nan Yu, Jiuyun Mi, Jingting Ren, Qi Ding, Yanzhong Gao, Min Qi, Youmin Guo. Pulmonary functions and imaging features of patients with chronic obstructive pulmonary disease combined with mild carbon dioxide retention[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2020, 13(01): 23-27.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfbjbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-6902.2020.01.005

https://zhfbjbzz.cma-cmc.com.cn/EN/Y2020/V13/I01/23

Figures/Tables 4

References 25

1	任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
2	From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. Available from: [ URL
3	Ley-Zaporozhan J, van Beek EJ: Imaging phenotypes of chronic obstructive pulmonary disease[J]. J Magnet Resonan Imag: JMRI, 2010, 32(6): 1340-1352.
4	Ranu H, Wilde M, Madden B. Pulmonary function tests[J]. Ulster Med J, 2011, 80(2): 84.
5	Hyatt RE, Scanlon PD, Nakamura M. Interpretation of pulmonary function tests[M]. Lippincott Williams & Wilkins, 2014: 32-45.
6	Kitaguchi Y, Yasuo M, Hanaoka M. Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation[J]. Int J Chron Obstruct Pulmon Disease, 2016, 11: 991.
7	Subramanian DR, Gupta S, Burggraf D, et al. Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography[J]. Eur Respir J, 2016, 48(1): 92.
8	Regan EA, Lynch DA, Curran-Everett D, et al. Clinical and Radiologic Disease in Smokers With Normal Spirometry[J]. Jama Intern Med, 2015, 175(9): 1539-1549.
9	Kreppein U, Litterst P, Westhoff M: [Hypercapnic respiratory failure. Pathophysiology, indications for mechanical ventilation and management] [J]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2016, 111(3): 196-201.
10	Almagro P, Barreiro B, Ochoa de Echaguen A, et al. Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease[J]. Respiration, 2006, 73(3): 311-317.
11	Pu J, Fuhrman C, Good WF, et al. A differential geometric approach to automated segmentation of human airway tree[J]. IEEE Trans Med Imaging, 2011, 30(2): 266-278.
12	Yu N, Xin X-M, Li Y, et al. Effect of computed tomography dose on quantitative measurement and automated segmentation of airway tree[J]. J Med Imag Health Inform, 2015, 5(7): 1519-1523.
13	Gevenois PA, De Vuyst P, de Maertelaer V, et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema[J]. Am J Respir Crit Care Med, 1996, 154: 187-192.
14	Bankier AA, De Maertelaer V, Keyzer C, et al. Thoracic imaging pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry[J]. Radiology，1999, 211: 851-858.
15	Madani A, Zanen J, de Maertelaer V, et al. Pulmonary emphysema：objective quantification at multi-detector row CT-comparison with macroscopic and microscopic morphometry[J]. Radiology, 2006, 238: 1036-1043.
16	赵春柳，周　敏. 慢性阻塞性肺疾病频繁急性加重表型研究进展[J]. 中华结核和呼吸杂志，2016, 39(12): 973-976.
17	陈亚红，姚婉贞. 慢性阻塞性肺疾病表型的研究进展[J]. 中华结核和呼吸杂志，2011, 34(8): 619-622.
18	Agusti A, Calverley PMA, Celli B, et al. Characterisation of COPD heterogeneity in theECLIPSE cohort[J]. Respirat Res, 2010, 11(1): 122-135.
19	Han MK, Agusti A, Calverley PM, et al. Chronic Obstructive Pulmonary Disease Phenotypes[J]. Am J Respir Crit Care Med, 2010, 182(5): 598-604.
20	陈亚红. 慢性阻塞性肺疾病急性加重临床表现的异质性[J]. 中华结核和呼吸杂志，2014, 37(4): 244-246.
21	Agustí A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype[J]. PloS one, 2012, 7(5): e37483.
22	[Moving towards a new focus on COPD. The Spanish COPD Guidelines (GESEPOC)][J]. Archivos de Bronconeumologia, 2011, 47(8): 379-381.
23	孙永昌. 慢性阻塞性肺疾病基于临床表型的分级和治疗——西班牙指南解读[J]. 中华结核和呼吸杂志，2014, 37(9): 652-654.
24	慢性阻塞性肺疾病急性加重诊治专家组：慢性阻塞性肺疾病急性加重诊治中国专家共识(草案) [J]. 中国呼吸与危重监护杂志，2013, 12(6): 541-551.
25	Malhotra R, Olsson H. Immunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification[J]. Expert Rev Respir Med, 2015, 9(2): 153-159.

肺气肿参数	例数	PD15_全肺	PD15_右肺	PD15_左肺	PD15_右上肺	PD15_右中肺	PD15_右下肺	PD15_左上肺	PD15_左下肺
非潴留组	61	-1 007.69±4.08	-1 007.39±4.29	-1 008.05±4.21	-1 006.82±4.37	-1 007.18±5.96	-1 007.36±4.63	-1 007.72±4.37	-1 008.2±4.6
轻度潴留组	48	-1 007.06±4.47^b	-1 006.65±4.79^b	-1 007.52±4.36^b	-1 006.69±5.75^a	-1 006.85±5.3^a	-1 006.42±5.37^a	-1 007.19±4.38^b	-1 007.81±4.72^a
呼衰组	38	-1 009.97±4.65^d	-1 009.53±5.01^d	-1 010.18±4.68^d	-1 009.21±5.6^d	-1 009.45±4.59^d	-1 009.21±5.06	-1 009.89±4.68^d	-1 010.18±4.95^d
F值		5.134	4.298	4.309	3.16	2.836	3.383	4.312	3.017
P值		0.007	0.015	0.015	0.045	0.062	0.037	0.015	0.052
肺气肿参数	例数	MED_全肺	MED_右肺	MED_左肺	MED_右上肺	MED_右中肺	MED_右下肺	MED_左上肺	MED_左下肺
非潴留组	61	-982.32±2.88	-982.04±2.94	-982.62±3.04	-981.8±3.02	-965.19±126.76	-982.03±3.14	-982.36±3.16	-982.54±3.1
轻度潴留组	48	-981.92±3.15^b	-981.69±3.37^b	-982.16±3.02^b	-981.51±3.59^a	-960.87±141.67	-981.43±3.64^a	-982±3.11^b	-982.18±3.24^a
呼衰组	38	-984.03±3.18^e	-983.7±3.31^d	-984.09±3.2^d	-983.33±3.69^d	-983.17±3.31	-983.2±3.3	-983.97±3.22^d	-983.78±3.19
F值		5.603	4.761	4.442	3.452	0.44	2.999	4.636	2.945
P值		0.005	0.01	0.013	0.034	0.645	0.053	0.011	0.056

肺气肿参数	例数	PD15_全肺	PD15_右肺	PD15_左肺	PD15_右上肺	PD15_右中肺	PD15_右下肺	PD15_左上肺	PD15_左下肺
非潴留组	61	-1 007.69±4.08	-1 007.39±4.29	-1 008.05±4.21	-1 006.82±4.37	-1 007.18±5.96	-1 007.36±4.63	-1 007.72±4.37	-1 008.2±4.6
轻度潴留组	48	-1 007.06±4.47^b	-1 006.65±4.79^b	-1 007.52±4.36^b	-1 006.69±5.75^a	-1 006.85±5.3^a	-1 006.42±5.37^a	-1 007.19±4.38^b	-1 007.81±4.72^a
呼衰组	38	-1 009.97±4.65^d	-1 009.53±5.01^d	-1 010.18±4.68^d	-1 009.21±5.6^d	-1 009.45±4.59^d	-1 009.21±5.06	-1 009.89±4.68^d	-1 010.18±4.95^d
F值		5.134	4.298	4.309	3.16	2.836	3.383	4.312	3.017
P值		0.007	0.015	0.015	0.045	0.062	0.037	0.015	0.052
肺气肿参数	例数	MED_全肺	MED_右肺	MED_左肺	MED_右上肺	MED_右中肺	MED_右下肺	MED_左上肺	MED_左下肺
非潴留组	61	-982.32±2.88	-982.04±2.94	-982.62±3.04	-981.8±3.02	-965.19±126.76	-982.03±3.14	-982.36±3.16	-982.54±3.1
轻度潴留组	48	-981.92±3.15^b	-981.69±3.37^b	-982.16±3.02^b	-981.51±3.59^a	-960.87±141.67	-981.43±3.64^a	-982±3.11^b	-982.18±3.24^a
呼衰组	38	-984.03±3.18^e	-983.7±3.31^d	-984.09±3.2^d	-983.33±3.69^d	-983.17±3.31	-983.2±3.3	-983.97±3.22^d	-983.78±3.19
F值		5.603	4.761	4.442	3.452	0.44	2.999	4.636	2.945
P值		0.005	0.01	0.013	0.034	0.645	0.053	0.011	0.056

肺功能	r	P值	PD15(Hu)	r	P值	MED(Hu)	相关系数	P值
MVV%pred	-0.451	<0.001	PD15_全肺	-0.325	0.002	MED_全肺	-0.333	0.002
FEV₁%	-0.536	<0.001	PD15_右肺	-0.317	0.003	MED_右肺	-0.327	0.002
FVC%Pred	-0.576	<0.001	PD15_左肺	-0.298	0.005	MED_左肺	-0.309	0.004
FEV₁/FVC	-0.273	0.011	PD15_右上肺	-0.281	0.009	MED_右上肺	-0.293	0.007
MMEF	-0.506	<0.001	PD15_右中肺	-0.305	0.004	MED_右中肺	-0.349	0.001
DLCO/VA	-0.277	0.011	PD15_右下肺	-0.288	0.007	MED_右下肺	-0.274	0.011
RV/TLC	0.386	<0.001	PD15_左上肺	-0.294	0.006	MED_左上肺	-0.308	0.004
			PD15_左下肺	-0.287	0.007	MED_左下肺	-0.295	0.006

肺功能	r	P值	PD15(Hu)	r	P值	MED(Hu)	相关系数	P值
MVV%pred	-0.451	<0.001	PD15_全肺	-0.325	0.002	MED_全肺	-0.333	0.002
FEV₁%	-0.536	<0.001	PD15_右肺	-0.317	0.003	MED_右肺	-0.327	0.002
FVC%Pred	-0.576	<0.001	PD15_左肺	-0.298	0.005	MED_左肺	-0.309	0.004
FEV₁/FVC	-0.273	0.011	PD15_右上肺	-0.281	0.009	MED_右上肺	-0.293	0.007
MMEF	-0.506	<0.001	PD15_右中肺	-0.305	0.004	MED_右中肺	-0.349	0.001
DLCO/VA	-0.277	0.011	PD15_右下肺	-0.288	0.007	MED_右下肺	-0.274	0.011
RV/TLC	0.386	<0.001	PD15_左上肺	-0.294	0.006	MED_左上肺	-0.308	0.004
			PD15_左下肺	-0.287	0.007	MED_左下肺	-0.295	0.006

[1]	Weiwei Cheng, Qing Zhang, Chengshi Zhang, Qiliong Feng, Rongrong Chen, Yunfeng Zhao. Correlation analysis between systemic immune-inflammation index and severity of acute exacerbation of chronic obstructive pulmonary disease [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(04): 580-584.
[2]	Jinfang Ma, Zhengguang He, Jinping Zheng. Efficacy and safety of inhaled ambroxol hydrochloride solution in treating chronic obstructive pulmonary disease patients with phlegm [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(04): 568-574.
[3]	Lingmei Kong, Xiaoyuan Xu, Liying Ma. Risk factors and prognosis of cognitive frailty in patients with chronic obstructive pulmonary disease [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(03): 407-410.
[4]	Mingchao Tan, Mingfu Gong, Jia Chen, Xi Zhang, Yajuan Sun. Classification and differential diagnosis of primary lung carcinoid based on imaging features [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(02): 218-222.
[5]	Enzhu Zhou, min Liu, Qiu Wan, Jingwen Liu, Lixin Tang. Clinical characteristics of acquired immunodeficiency syndrome complicated with chronic obstructive pulmonary disease [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(01): 78-82.
[6]	Mingfu Yang, Yongxing Wang. Curative effect comparison between HFNC and NPPV in patients with AECOPD complicated with type Ⅱ respiratory failure [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(06): 804-808.
[7]	Li Li, Lili Xiang, Fei Tou. Relationship between cardiac ultrasound parameters and extubation outcome in AECOPD patients with respiratory failure [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(06): 799-803.
[8]	Jiamin Liu, Xiao Xie, Mei Li. Efficacy of fiberoptic bronchoscopy combined with ambroxol in the treatment of COPD with respiratory failure and its effects on blood gas indicators, pulmonary function and blood lactate level [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(05): 640-644.
[9]	Xi Gan, Xin Liao. Correlation analysis of tumor deposition near gastric cancer with CT imaging characteristics, serum indexes and pathological characteristics [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(05): 422-425.
[10]	Ke Zhang, Erming Zhang, Wei Yan, Shitou Ma, Xinhua An, Caoxin Bao, Pingchao Xiang. Correlation between lung function and smoking status in patients with preserved-ratio impaired spirometry and chronic obstructive pulmonary disease over 40 years of age in Shijingshan district of Beijing [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(02): 122-127.
[11]	Hongyan Cheng, Dongping Wang, Jingli Zhao, Yao He, Xundi Bao. Clinical characteristics of pulmonary nocardiosis [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(01): 35-40.
[12]	Rongju Wu, Pingchao Xiang. Correlation between frequent exacerbation phenotype of chronic obstructive pulmonary disease and inflammatory markers [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(09): 939-947.
[13]	Ting Zhou, Peipei Sun, Erming Zhang, Xinhua An, Pingchao Xiang. Investigation on current status of diagnosis of chronic obstructive pulmonary disease among residents aged 40 and above in Shijingshan District, Beijing [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 790-797.
[14]	Peipei Sun, Erming Zhang, Yanwei Shi, Chunyan Zhao, Pingping Song, Shuo Zhang, Ke Zhang, Yujiao Zhou, Can Zhao, Wei Yan, Rongju Wu, Liping Song, Weian Guo, Shitou Ma, Xinhua An, Caoxin Bao, Pingchao Xiang. Prevalence and risk factors of chronic obstructive pulmonary disease in residents aged 40 years and above in Shijingshan district of Beijing [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 711-719.
[15]	Xiu He, Di Ao, Zheng Yang, Xiaohua Lin. Efficacy of a modified respiratory support strategy on patients with acute exacerbations of chronic obstructive pulmonary disease in combination with type II respiratory failure [J]. Chinese Journal of Hygiene Rescue(Electronic Edition), 2024, 10(03): 140-144.

Please choose a citation manager

Content to export